Protalix BioTherapeutics, Inc. SEC filings PLX

Protalix BioTherapeutics, Inc. has 972 filings in SEC EDGAR's recent list, going back to Aug 13, 1996. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
10-K Annual report Mar 18, 2026 Dec 31, 2025
ARS Annual report to shareholders May 8, 2025 Dec 31, 2024
10-K Annual report Mar 17, 2025 Dec 31, 2024
ARS Annual report to shareholders May 17, 2024 Dec 31, 2023
10-K Annual report Mar 14, 2024 Dec 31, 2023
ARS Annual report to shareholders May 19, 2023 Dec 31, 2022
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
10-K Annual report Feb 27, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K/A Amended annual report Apr 30, 2021 Dec 31, 2020
10-K Annual report Mar 30, 2021 Dec 31, 2020
10-K Annual report Mar 12, 2020 Dec 31, 2019
10-K Annual report Mar 18, 2019 Dec 31, 2018
10-K Annual report Mar 6, 2018 Dec 31, 2017
10-K Annual report Mar 16, 2017 Dec 31, 2016
10-K/A Amended annual report Apr 22, 2016 Dec 31, 2015
10-K Annual report Mar 8, 2016 Dec 31, 2015
ARS Annual report to shareholders Oct 27, 2015 Dec 31, 2014
10-K Annual report Mar 12, 2015 Dec 31, 2014
ARS Annual report to shareholders Oct 22, 2014 Dec 31, 2013
10-K Annual report Mar 13, 2014 Dec 31, 2013
ARS Annual report to shareholders Oct 1, 2013 Dec 31, 2012
10-K Annual report Feb 28, 2013 Dec 31, 2012
ARS Annual report to shareholders May 30, 2012 Dec 31, 2011
10-K Annual report Feb 27, 2012 Dec 31, 2011
ARS Annual report to shareholders Sep 23, 2011 Dec 31, 2010
10-K Annual report Feb 23, 2011 Dec 31, 2010
ARS Annual report to shareholders Oct 7, 2010 Dec 31, 2009
10-K Annual report Feb 26, 2010 Dec 31, 2009
10-K Annual report Mar 6, 2009 Dec 31, 2008
10-K Annual report Mar 17, 2008 Dec 31, 2007
10-K/A Amended annual report Jul 13, 2007 Dec 31, 2006
10-K Annual report Mar 30, 2007 Dec 31, 2006
10-K Annual report Mar 30, 2006 Dec 31, 2005
10-K Annual report Mar 31, 2005 Dec 31, 2004
10-K Annual report Mar 30, 2004 Dec 31, 2003
10-K Annual report Mar 28, 2003 Dec 31, 2002

Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
PLX (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Hackensack, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1006281
Former names
ORTHODONTIX INC (until Feb 22, 2007); EMBASSY ACQUISITION CORP (until Mar 31, 1998)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.